CANCER 52

Registered charity 1174569 · accounts filings on the Charity Commission register

To promote and protect the health and sufferers of rare and less common cancers for the public benefit by :(a) Promoting understanding, awareness and research about rare and less common cancers(b) acting as a collective voice and advocating needs of individuals affected by a rare or less common cancers(c)supporting not-for-profit organisations in field of rare and less common cancers

Objects

TO PROMOTE AND PROTECT THE HEALTH OF SUFFERERS OF RARE AND LESS COMMON CANCERS FOR THE PUBLIC BENEFIT BY:(A) ADVANCING AND PROMOTING THE UNDERSTANDING, AWARENESS, RESEARCH AND LEARNING ABOUT RARE AND LESS COMMON CANCERS;(B) ACTING AS A COLLECTIVE VOICE AND ADVOCATING FOR THE NEEDS OF INDIVIDUALS AFFECTED BY A RARE OR LESS COMMON CANCER IN ORDER TO IMPROVE THE OUTCOMES OF DIAGNOSIS, TREATMENT AND LONG-TERM SUPPORT; AND(C) SUPPORTING, REPRESENTING AND EMPOWERING NOT-FOR-PROFIT ORGANISATIONS WORKING IN THE FIELD OF RARE AND LESS COMMON CANCER.

The charity’s charitable objects and area of benefit, quoted from its governing document as held on the Charity Commission register.

Causes: General Charitable Purposes · The Advancement Of Health Or Saving Of Lives · Other Charitable Purposes · website · Get email alerts

Latest income
£363k
Latest spending
£349k
Registered
2017
Accounts read
FY2025

Financial health, per its FY2025 accounts

The accounts state that Cancer52 generated a surplus of £14,819 for the year ended 31 March 2025, with total income of £363,420 against expenditure of £348,601. Per the trustees' report, unrestricted reserves increased to £65,732, which the Board considers sufficient to cover five months of operational running costs in line with their stated policy of holding between five and seven months' expenditure.

Automated summary of the FY2025 accounts; the evidenced findings below carry the verbatim passages.

What the accounts disclose

Reserves policy: five to seven months' unrestricted annual expenditure (held: £66k)
“This means that we aim to hold between five and seven months’ unrestricted annual expenditure in reserve.”
Per its FY2025 accounts as filed with the Charity Commission.

Accounts independently examined (not a full audit). Discloses 5 of 6 completeness components.

Policies the charity declares

In its annual return the charity told the Commission that it has the policies listed below. This is self-declared: it is not verified by the Commission or by this site, and it is not evidence of how a policy works in practice.

Funders the charity credits

Named as funders/supporters on the charity’s own website (the charity’s claim, distinct from accounts-verified grants).

Public profiles (found on the charity’s own website): facebook

Trustees · trustee networks

Trustee list from the Charity Commission register (current, not historical).

Operates in: Northern Ireland · Scotland · Throughout England And Wales

Income and spending

Financial year endIncomeSpending
31/03/2025£363k£349k
31/03/2024£231k£269k
31/03/2023£177k£198k
31/03/2022£145k£151k
31/03/2021£176k£126k

Common questions

Is CANCER 52 financially healthy?

Per its FY2025 accounts: The accounts state that Cancer52 generated a surplus of £14,819 for the year ended 31 March 2025, with total income of £363,420 against expenditure of £348,601. Per the trustees' report, unrestricted reserves increased to £65,732, which the Board considers sufficient to cover five months of operational running costs in line with their stated policy of holding between five and seven months' expenditure. Its FY2025 accounts were independently examined.

Government & lottery funding

Grants to this charity published as open data by government and lottery funders (360Giving).

FunderDateAmountPurpose
The National Lottery Community Fund31/08/2023£466kSupporting Cancer52's organisational development and growth

Funders of similar charities

Funders whose accounts show grants to charities similar to this one (and no recorded grant to this charity) — a starting list for fundraisers.

Charities like this

Semantically similar by activities and financial character, from our analysed corpus. Compare with CANCER RESEARCH WALES.

Side by side with its peers

CharityIncomeTop pay bandStaff >£60kReserves vs policyFundraising costGoing concern
CANCER 52£363k—0within—no doubt
CANCER RESEARCH WALES FY2026£5.9m——unclear—no doubt
EHE RARE CANCER CHARITY (UK) FY2024£133k—0unclear—no doubt
SARCOMA UK FY2025£4.6m——above26.0%no doubt
THE CHILDREN'S CANCER AND LEUKAEMIA GROUP FY2025£5.5m——below—no doubt
CANCER AWARENESS TRUST FY2024£1.1m£100,001 - £110,000—unclear—no doubt

Each row is that charity’s latest analysed filing; every value is quote-backed on its own page.